{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:44:08Z","timestamp":1767134648953,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":43,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001717","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:17:17Z","timestamp":1069366637000},"source":"Crossref","is-referenced-by-count":0,"title":["Depot perphenazine decanoate and enanthate for schizophrenia"],"prefix":"10.1002","author":[{"given":"A","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Quraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2000,1,24]]},"reference":[{"key":"10.1002\/14651858.CD001717-BIB1|cit1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0447.1980.tb07085.x","article-title":"Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients","volume":"61","author":"Ahlfors","year":"1980","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"supp 322","key":"10.1002\/14651858.CD001717-BIB2|cit2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.1985.tb08537.x","article-title":"Perphenazine decanoate vs perphenazine enanthate","volume":"72","author":"Knudsen","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001717-BIB3|cit3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0447.1973.tb08446.x","article-title":"Clinical experience with depot neuroleptics","volume":"246","author":"Bakke","year":"1973","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001717-BIB4|cit4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02245440","article-title":"A long term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanaote in schizophrenic patients","volume":"114","author":"Dencker","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD001717-BIB5|cit5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02316862","article-title":"Perphenazine decanoate and cis(z)-flupenthixol decanoate in maintenance treatment of schizophrenic outpatients","volume":"105","author":"Kistrup","year":"1991","journal-title":"Psychopharmacology"},{"issue":"supp 322","key":"10.1002\/14651858.CD001717-BIB6|cit6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0447.1985.tb08538.x","article-title":"Long-term depot neuroleptic treatment with perphenazine decanoate I","volume":"76","author":"Knudsen","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"supp 322","key":"10.1002\/14651858.CD001717-BIB7|cit7","first-page":"40","article-title":"Long-term depot neuroleptic treatment with perphenazine decanoate II","volume":"76","author":"Knudsen","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"supp 322","key":"10.1002\/14651858.CD001717-BIB8|cit8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1985.tb08536.x","article-title":"Perphenazine decanoate in sesame oil vs perphenazine enanthate in sesame oil","volume":"76","author":"Knudsen","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001717-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426949","article-title":"Effects of perphenazine enanthate injections on rolactin levels in plasma from schizophrenic women and men","volume":"57","author":"Lindholm","year":"1978","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD001717-BIB10|cit10","first-page":"665","article-title":"A double blind crossover study comparing haloperidol decanoate and perphanazine enantate","volume":"39","author":"Rapp","year":"1986","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD001717-BIB11|cit11","first-page":"227","article-title":"Experience with perphenazine-enanthate in the maintenance therapy of schizophrenic psychoses","volume":"24","author":"Rysanek","year":"1982","journal-title":"Activas Nervosa Superior (Praha)"},{"key":"10.1002\/14651858.CD001717-BIB12|cit12","first-page":"534","volume":"50","author":"Eufe","year":"1979","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD001717-BIB13|cit13","series-title":"Symposium Espo","article-title":"Pharmacokinetics of oral and depot neuroleptics-Clinical relevance","author":"Aaes-Jorgenson"},{"key":"10.1002\/14651858.CD001717-BIB14|cit14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2273.1994.tb01198.x","article-title":"Patient compliance with short-term topical aural antibiotic therapy","volume":"19","author":"Agius","year":"1994","journal-title":"Clincal Otolaryngology"},{"key":"10.1002\/14651858.CD001717-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD001717-BIB16|cit16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2165\/00002018-199410060-00005","article-title":"Long term depot antipsychotics. A risk benefit assessment","volume":"10","author":"Barnes","year":"1994","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD001717-BIB17|cit17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.276.8.637","article-title":"Improving the quality of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001717-BIB18|cit18","volume-title":"Gedragsbeoordeling in het psychiatrisch ziekenhuis. De PUK schales voor gedragsbeoordeling","author":"Beyaert","year":"1966"},{"key":"10.1002\/14651858.CD001717-BIB19|cit19","first-page":"233","article-title":"Extrapyramidal symptom rating scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Canadian Journal of Neurological Science"},{"key":"10.1002\/14651858.CD001717-BIB20|cit20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.146.5.464","article-title":"Long-term depot maintenance of chronic schizophrenic out-patients: the seven-year follow-up of the medical research council fluphenazine\/ placebo trial","volume":"146","author":"Curson","year":"1985","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001717-BIB21|cit21","volume-title":"The neuropsychology of schizophrenia","author":"David","year":"1994"},{"issue":"suppl 1","key":"10.1002\/14651858.CD001717-BIB22|cit22","first-page":"2","article-title":"The natural course of schizophrenia and effective maintenance drug therapy","volume":"6","author":"Davis","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD001717-BIB23|cit23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003495-199447050-00004","article-title":"Depot antipsychotic drugs - place in therapy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"issue":"supp 279","key":"10.1002\/14651858.CD001717-BIB24|cit24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0447.1980.tb07084.x","article-title":"Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study","volume":"61","author":"Dencker","year":"1980","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001717-BIB25|cit25","unstructured":"Department of Health, NHS Executive Burdens of disease: a discussion document HMSO 1996"},{"key":"10.1002\/14651858.CD001717-BIB26|cit26","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, (DSM-II)","volume":"2","year":"1968"},{"key":"10.1002\/14651858.CD001717-BIB27|cit27","first-page":"124","volume-title":"ECDEU Assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD001717-BIB28|cit28","volume-title":"Compliance in health care","author":"Haynes","year":"1979"},{"key":"10.1002\/14651858.CD001717-BIB29|cit29","first-page":"157","article-title":"Prescribing patterns of neuroactive drugs in 98 schzophrenic patients","volume":"26","author":"Heresco-Levy","year":"1989","journal-title":"Israel Journal of Psychiatry and Related Sciences"},{"key":"10.1002\/14651858.CD001717-BIB30|cit30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.1.5854.633","article-title":"Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo controlled trial","volume":"1","author":"Hirsch","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001717-BIB31|cit31","first-page":"799","article-title":"NOSIE-30: a treatment sensitive ward behavior scale","volume":"10","author":"Honigfeld","year":"1962","journal-title":"Psychological Reports"},{"issue":"supp 2","key":"10.1002\/14651858.CD001717-BIB32|cit32","first-page":"1","volume":"24","author":"INSERM","year":"1969","journal-title":"Bull Last Rech Med"},{"key":"10.1002\/14651858.CD001717-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0264180100000904","article-title":"Schizophrenia: manifestations, incidence and course indifferent cultures. A World Health Organization ten-country study","volume":"20","author":"Jablensky","year":"1992","journal-title":"Psychological Medicine (Monograph Supplement)"},{"key":"10.1002\/14651858.CD001717-BIB34|cit34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1192\/bjp.156.6.827","article-title":"Drug prescribing for schizophrenic out-patients on depot injections. Repeat surveys over 18 years","volume":"156","author":"Johnson","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001717-BIB35|cit35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","article-title":"Guidelines for depot antipsychotic treatment in schizophrenia","volume":"8","author":"Kane","year":"1998","journal-title":"European Neuropschopharmacology"},{"key":"10.1002\/14651858.CD001717-BIB36|cit36","author":"Marshall","year":"1998","journal-title":"Personal communication"},{"key":"10.1002\/14651858.CD001717-BIB37|cit37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001717-BIB38|cit38","volume-title":"The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration","author":"Mulrow","year":"1999"},{"key":"10.1002\/14651858.CD001717-BIB39|cit39","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"4","key":"10.1002\/14651858.CD001717-BIB40|cit40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08039487109094674","article-title":"Chronic schizophrenia treated with depot perphenazine","volume":"25","author":"Petersson","year":"1971","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001717-BIB41|cit41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.272.2.125","article-title":"Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals","volume":"272","author":"Schulz","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001717-BIB42|cit42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0895-4356(94)00141-C","article-title":"Cost-effectiveness comparisons using \"real world\" randomized trials: the case of new antidepressant drugs","volume":"48","author":"Simon","year":"1995","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001717-BIB43|cit43","doi-asserted-by":"crossref","first-page":"s11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001717.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,7,20]],"date-time":"2005-07-20T00:00:00Z","timestamp":1121817600000}}],"container-title":["The Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:03:45Z","timestamp":1704960225000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1,24]]},"references-count":43,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001717","relation":{},"subject":[],"published":{"date-parts":[[2000,1,24]]}}}